stockrowGlaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +110.7%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Net income
Glaukos Corporation's net income for fiscal 2025 was −$187.7M, compared with −$146.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$169.8M. Over the past ten years it has ranged from −$187.7M (fiscal 2025) to $15.4M (fiscal 2019) — the current reading is the lowest in ten years. Net income has fallen for 4 consecutive fiscal years. Glaukos Corporation ranks 146th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$187.7M | — |
| FY2024 | −$146.4M | — |
| FY2023 | −$134.7M | — |
| FY2022 | −$99.2M | — |
| FY2021 | −$49.6M | — |
| FY2020 | −$120.3M | — |
| FY2019 | $15.4M | — |
| FY2018 | −$13.0M | — |
| FY2017 | −$92.0K | — |
| FY2016 | $4.5M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $2.0M | — |
| Jun 2026 | −$18.4M | — |
| Mar 2026 | −$19.8M | — |
| Dec 2025 | −$133.7M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $768.8M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $616.6M |
| BIO Bio-Rad Laboratories, Inc. compare | $616.6M |
| GMED Globus Medical, Inc. compare | $557.6M |
| PODD Insulet Corporation compare | $428.8M |
| PEN Penumbra, Inc. compare | $157.0M |
| BRKR Bruker Corporation compare | −$115.7M |
| GKOS Glaukos Corporation | −$169.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on GKOS
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement